[
  {
    "variant_id": {
      "Gene": "PARK2",
      "Protein_Change": {
        "ref": "L858R",
        "alt": "R117H",
        "position": "117"
      },
      "variant_string_id": "PARK2 L858R"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Define the disease mechanism",
        "extracted_paper_info": "The authors hypothesize that PARK2 mutations can disrupt mitochondrial function, potentially leading to impaired neuronal survival and neurodegeneration.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states that PARK2 mutations are linked to neuronal dysfunction and potential degeneration, indicating a pathogenic mechanism."
      },
      {
        "step_name": "Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The authors utilize a combination of techniques, including gene expression analysis and protein interaction assays, to assess the impact of PARK2 mutations on cellular processes.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly highlights the use of various assays (gene expression, protein interaction) to explore the effects of mutations."
      },
      {
        "step_name": "Evaluate validity of specific instances of assays",
        "extracted_paper_info": "The authors propose a combined approach to assessing the impact of mutation on cellular pathways, including the use of various assays to quantify the effects of mutations.",
        "judgment": "Yes",
        "reasoning": "The paper details the method of evaluation of particular variant results as described by the authors."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The evidence strongly points to PARK2 as a tumor suppressor on 6q25.2-q27, potentially contributing to neuronal dysfunction when mutated in the germline, thereby potentially impacting oncogenesis when altered in non-neuronal somatic cells."
  }
]